2022
DOI: 10.1158/1538-7445.am2022-1334
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 1334: MerTK tumorigenesis and immune evasion mechanisms in triple negative breast cancer

Abstract: Triple negative breast cancer (TNBC) cells lack estrogen, progesterone, and HER2 receptors. TNBC tends to be more aggressive than most types of breast cancer and is more likely to recur even after surgery and treatment. Recently, a few targeted therapies were approved for TNBC, but additional molecular targeting agents are still needed. Previous studies have found that activated MerTK is associated with many types of human cancers, including breast cancer. In this study, we focused on MerTK expression and its … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles